← Eichor
Study identifier: NCT06780813 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Supplemental High Flow Oxygen to Reduce Infections in Obese Gynecological Cancer Patients

Condition: Supplemental Oxygen · Gynecological Cancer · Surgical Site Infections  ·  Sponsor: National and Kapodistrian University of Athens

PhaseNA
Planned participants400
Who can joinFemale, 18 Years to 85 Years
Healthy volunteersNo

About this study

The incidence of surgical-site infection (SSI) and complications related to wound healing reaches 10-20% of gynecological cancer patients. Each complication may dramatically prolong the hospitalization period and increase the economic burden of hospital care. Appropriate wound care and tissue oxygenation are of special importance for wound healing. Assuming adequate perfusion, the easiest, safest, and most effective way to improve tissue oxygenation is to increase the fraction of inspired oxygen. However, there is considerable controversy as to whether supplemental oxygen actually reduces SSI and healing-related complications as to date, there is absence of relevant data.

This description comes directly from the study's public registry record.

Talk to the study team

Vasilios Pergialiotis, Assistant Professor  ·  +302132162291  ·  pergialiotis@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

First department of Obstetrics and GynecologyAthens, GreeceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06780813